Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 22

Results For "Post"

1357 News Found

Lyka Labs posts Q2 FY24 loss at Rs. 48.65 lakhs
News | November 03, 2023

Lyka Labs posts Q2 FY24 loss at Rs. 48.65 lakhs

Lyka Labs has reported total income of Rs. 28.23 crores during the period ended September 30, 2023


Morepen Laboratories posts Q2 FY24 consolidated PAT at Rs. 21.25 Cr
News | November 03, 2023

Morepen Laboratories posts Q2 FY24 consolidated PAT at Rs. 21.25 Cr

Morepen Laboratories has reported total income of Rs. 425 crores during the quarter ended September 30, 2023


Lincoln Pharmaceuticals posts Q2 FY24 consolidated PAT at Rs. 27.65 Cr
News | November 03, 2023

Lincoln Pharmaceuticals posts Q2 FY24 consolidated PAT at Rs. 27.65 Cr

Lincoln Pharmaceuticals has reported total income of Rs. 164.68 crores during the period ended September 30, 2023


Dr Lal Path Labs posts Q2 FY24 consolidated PAT at Rs. 109.3 Cr
News | November 03, 2023

Dr Lal Path Labs posts Q2 FY24 consolidated PAT at Rs. 109.3 Cr

Dr. Lal Path Labs has reported total income of Rs. 619.4 crores during the period ended September 30, 2023


Jubilant Ingrevia posts Q2 FY24 consolidated PAT at Rs. 57.49 Cr
News | November 02, 2023

Jubilant Ingrevia posts Q2 FY24 consolidated PAT at Rs. 57.49 Cr

The company has posted net profit of Rs.115.08 crores for half year ended September 30, 202


Thyrocare Technologies posts Q2 FY24 consolidated PAT at Rs. 20.34 Cr
News | November 01, 2023

Thyrocare Technologies posts Q2 FY24 consolidated PAT at Rs. 20.34 Cr

Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023


Ajanta Pharma posts Q2 FY24 consolidated PAT at Rs. 195.30 Cr
News | November 01, 2023

Ajanta Pharma posts Q2 FY24 consolidated PAT at Rs. 195.30 Cr

Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023


Pfizer posts Q3 loss as Covid-19 revenues shrink
News | November 01, 2023

Pfizer posts Q3 loss as Covid-19 revenues shrink

Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion


RPG Life Sciences posts Q2 FY24 PAT at Rs. 25.86 Cr
News | October 23, 2023

RPG Life Sciences posts Q2 FY24 PAT at Rs. 25.86 Cr

RPG Life Sciences has reported total income of Rs. 155.41 crores during the period ended September 30, 2023


Indoco Remedies posts consolidated Q2FY24 PAT at Rs. 35.08 Cr
News | October 23, 2023

Indoco Remedies posts consolidated Q2FY24 PAT at Rs. 35.08 Cr

The company has reported total income of Rs. 486.16 crores during the period ended September 30, 2023